| Developers: | TransMed7 |
| Date of the premiere of the system: | August 2022 |
| Branches: | Pharmaceuticals, Medicine, Healthcare |
2022: Breast biopsy device announcement
On August 10, 2022, TransMed7 announced that the first clinical cases of the final commercial version of the Sparrow device (a member of the new SpeedBird family - vacuum assisted single-injection multiple-sampling breast biopsy (SIMC) devices) were successfully conducted by Dr. Edgar Staren, a reputable surgeon and former president of the American Society of Breast Surgeons (ASBrS).
The SpeedBird and Concorde platforms are based on the patented TransMed7 working element of the Zero5, consisting of a fused single element designed from 3 hypothubes cut by a laser and welded to form articulated twin cutting blades at the end of a rotating open tube. This element neatly penetrates the tissues, cuts out the core, dissects them, and provides a pathway for transporting multiple tissue samples through a closed fluid control system and vacuum system into a removable chamber.
Zero5 forward coring technology allows these devices to reliably and consistently obtain full-layer samples of uniform diameter with intact architecture from all different soft tissues. It was designed as an entirely new mechanism designed to deliver superior results while reducing costs, as well as ease of use for rapid training and implementation.
The new Sparrow device, which is designed to manually monitor core length and automatically transport tissues and is designed to be the ultimate "terminator" of single-injection devices - a single "snapgun" sample used for most patients.
 | Breast biopsies using TransMed7 's SpeedBird SIMC devices require minimal tuning, are very easy to perform thanks to their extreme ultrasound visibility, are very well tolerated by patients and take only a few minutes per clinical case, says Staren. In all the cases I conducted, the core samples were simply excellent and provided exactly what our team needed to plan the therapeutic treatment for each patient. |  |
| | I can even say that these first cases cover the spectrum of the most complex breast biopsies that doctors can encounter, and the devices have shown brilliant results, he added.[1] | |
Notes
| The site content is translated by machine translation software powered by PROMT. The machine-translated articles are not always perfect and may contain errors in vocabulary, syntax or grammar. Read original article If you find inaccuracies or errors in the results of machine translation, please write to editor@tadviser.ru. We will make every effort to correct them as soon as possible. |